These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27139989)

  • 1. FDA rejects first cognitive claim for antidepressant.
    Mullard A
    Nat Rev Drug Discov; 2016 May; 15(5):299. PubMed ID: 27139989
    [No Abstract]   [Full Text] [Related]  

  • 2. Congress investigates FDA's handling of antidepressant safety information.
    Young D
    Am J Health Syst Pharm; 2004 Nov; 61(21):2228, 2230, 2232 passim. PubMed ID: 15552624
    [No Abstract]   [Full Text] [Related]  

  • 3. Vortioxetine (Brintellix®) and levomilnacipran (Fetzima®): the two newest additions to the antidepressant formulary.
    Roman MW; Wilkinson SM
    Issues Ment Health Nurs; 2014 Dec; 35(12):972-4. PubMed ID: 25426751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What ails the FDA?
    Okie S
    N Engl J Med; 2005 Mar; 352(11):1063-6. PubMed ID: 15784660
    [No Abstract]   [Full Text] [Related]  

  • 5. Paroxetine and the FDA.
    Brent DA
    J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):127-8. PubMed ID: 14971062
    [No Abstract]   [Full Text] [Related]  

  • 6. Paroxetine and the FDA.
    Riddle MA
    J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):128-30. PubMed ID: 14964296
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA alert on antidepressants for youth.
    Mitka M
    JAMA; 2003 Nov; 290(19):2534. PubMed ID: 14625316
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug approval and drug effectiveness.
    Spielmans GI; Kirsch I
    Annu Rev Clin Psychol; 2014; 10():741-66. PubMed ID: 24329178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine and the FDA.
    Connor DF
    J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):127. PubMed ID: 14726715
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA-Approved Drugs to Treat Major Depressive Disorder (MDD).
    J Psychosoc Nurs Ment Health Serv; 2024 Jul; 62(7):5-6. PubMed ID: 38976854
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients' views on suicidality and antidepressants.
    Muroff JR; Kim SY
    Psychiatr Serv; 2006 May; 57(5):723-4. PubMed ID: 16675775
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure rate and "professional subjects" in clinical trials of major depressive disorder.
    Shiovitz TM; Zarrow ME; Shiovitz AM; Bystritsky AM
    J Clin Psychiatry; 2011 Sep; 72(9):1284; author reply 1284-5. PubMed ID: 21951988
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA approves first drug for Parkinson disease psychosis.
    Mullard A
    Nat Rev Drug Discov; 2016 Jun; 15(6):375. PubMed ID: 27245388
    [No Abstract]   [Full Text] [Related]  

  • 14. Finding studies on reboxetine: a tale of hide and seek.
    Wieseler B; McGauran N; Kaiser T
    BMJ; 2010 Oct; 341():c4942. PubMed ID: 20940211
    [No Abstract]   [Full Text] [Related]  

  • 15. 2015 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2016 Feb; 15(2):73-6. PubMed ID: 26837582
    [No Abstract]   [Full Text] [Related]  

  • 16. Will FDA relinquish the "gold standard" for new drug approval? Redefining "substantial evidence" in the FDA Modernization Act of 1997.
    Kulynych J
    Food Drug Law J; 1999; 54(1):127-49. PubMed ID: 11758555
    [No Abstract]   [Full Text] [Related]  

  • 17. Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New Class.
    Kim J; Farchione T; Potter A; Chen Q; Temple R
    N Engl J Med; 2019 Jul; 381(1):1-4. PubMed ID: 31116916
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA and drug approval.
    Faich GA
    J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):24S. PubMed ID: 8770838
    [No Abstract]   [Full Text] [Related]  

  • 19. The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug Development.
    Stockbridge N; Miller K; Amur S; Hillebrenner M; Zuckerman B; Fiuzat M; Califf RM
    JACC Heart Fail; 2017 Jan; 5(1):67-70. PubMed ID: 28034379
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA accepts NDA for priority review of TMC125.
    AIDS Patient Care STDS; 2007 Oct; 21(10):779. PubMed ID: 17992720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.